Craig-Hallum initiated coverage of Myriad Genetics (MYGN) with a Buy rating and $29 price target Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing ...

Myriad Genetics (MYGN) and INTERLINK Care Management announced an agreement designed to enhance education and access to hereditary cancer testing for CancerCARE for Life members. The agreement ...

Researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital, Baylor Genetics and collaborating institutions provided ...

Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during reproduction. The map marks a major step in the understanding of genetic ...

Datar Cancer Genetics (DCG) has launched a revolutionary video-reporting service for in-vitro chemosensitivity testing, powered by AI-driven... Datar Cancer Genetics (DCG) today announced the ...

GeneDx has a big market in mind for its genetic testing: every newborn baby. The 24-year-old-company wants to make the testing common at birth. The goal: Identify potential diseases or conditions ...

One intriguing finding was the genetic correlation between anterior uveitis and inflammatory bowel diseases (IBD). IBD includes ulcerative colitis, Crohn’s disease, and microscopic colitis. In ...

More than 80% of all genetic research is conducted in individuals of European ancestry 1, raising concerns that Indigenous people and other under-represented groups might not benefit from the ...

-Datar Cancer Genetics presenta un revolucionario análisis de sangre informado basado en el tumor para el control de enfermedades residuales El análisis de sangre Target-MRD utiliza una ...